Quantcast

Latest Orphan drug Stories

2013-09-13 23:01:19

Register Now to Attend Premier Conference on Orphan Product Development, Emerging Markets and Outlook for Investment. Horsham, PA (PRWEB) September 13, 2013 The early registration deadline for the third annual U.S. Conference on Rare Diseases and Orphan Products is Monday, Sept. 16. Co-sponsored by the National Organization for Rare Disorders (NORD) and DIA in collaboration with the Food and Drug Administration (FDA) and EURORDIS (Rare Diseases Europe), the conference will take place from...

2013-08-29 23:04:59

New research study “Europe Orphan Drugs Pipeline Analysis” elaborated by PNS Pharma has been recently published by Market Publishers Ltd. According to the report, the share of orphan drugs R&D of total biopharma industry’s R&D is set to keep on increasing significantly in future. London, UK (PRWEB) August 29, 2013 Since 2000 onwards, Europe has witnessed over 50 treatments for rare diseases being approved, when the European Commission introduced incentives to encourage the...

2013-08-10 23:01:41

RnRMarketResearch.com adds Latest Report on “Orphan Drugs Partnering Terms and Agreements” to its store. The report provides an understanding and analysis of how and why companies enter orphan drugs partnering deals. Dallas, TX (PRWEB) August 10, 2013 The Orphan Drugs Partnering Terms and Agreements report provide an understanding and access to the orphan drugs partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in orphan drugs partnering...

2013-08-05 23:02:03

Bill Corr to Kick Off Conference 30 Years After Passage of Orphan Drug Act. Horsham, PA (PRWEB) August 05, 2013 Bill Corr, deputy secretary of the U.S. Department of Health and Human Services, will deliver the keynote address at the third annual U.S. Conference on Rare Diseases and Orphan Products in Bethesda, Md., on Oct. 7, 2013. Corr was vital in the passage of the Orphan Drug Act (ODA), serving as counsel to the U.S. House of Representatives’ Subcommittee on Health and the...

2013-07-23 23:04:05

Key Stakeholders in Rare Disease Community to Discuss the New Era in Health Care Bethesda, MD (PRWEB) July 23, 2013 Patient advocates, industry leaders, researchers, regulatory officials, investors and thought leaders dedicated to advancing the development of and access to therapies for rare diseases will come together for the third annual U.S. Conference on Rare Diseases and Orphan Products, held in Bethesda, Oct. 7–9. The conference is hosted by DIA and the National Organization for...

2013-07-16 23:17:16

In the new report, Global Markets For Orphan Drugs (PHM038D), from BCC Research, the global market for orphan drugs was valued at $82.6 billion in 2011 and nearly $86 billion in 2012. The report forecasts total market value to reach $112 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 5.4%. Wellesley, MA (PRWEB) July 16, 2013 In the new report, GLOBAL MARKETS FOR ORPHAN DRUGS (PHM038D), from BCC Research (http://www.bccresearch.com), the global...

2013-07-06 23:01:16

Transparency Market Research add new "Orphan Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018" market research report to its report store. Browse the report, visit http://www.transparencymarketresearch.com/orphan-drugs-market.html. Albany, New York (PRWEB) July 06, 2013 Orphan drugs are specific pharmaceutical agents which are developed for treatment of orphan or rare diseases. Orphan disease, according to laws of various countries,...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related